Cat. No.
MABL-3838
Application
IB, WB, Block, ELISA, IF, IHC
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
OV-TL3
From
Recombinant Antibody
Specificity
The antibody binds to OA3 with an affinity (Kd) of 0.71 nM.
Alternative Names
OA3 TA; Tumour-associated antigen OA3
UniProt
Immunogen
Tumor cell suspension prepared from an ovarian endometrioid carcinoma.
Application Notes
The antibody binds specifically to OA3, a cell surface glycoprotein tumour-associated antigen with a multi membrane spanning structure. The antigen is expressed by the major histological types of ovarian carcinoma, and antibodies directed against the antigen can be used for both the diagnosis and treatment of primary and metastatic ovarian carcinomas.
Antibody First Published
Poels LG, Peters D, van Megen Y, Vooijs GP, Verheyen RN, Willemen A, van Niekerk CC, Jap PH, Mungyer G, Kenemans P. Monoclonal antibody against human ovarian tumor-associated antigens. J Natl Cancer Inst. 1986 May;76(5):781-91. PMID:3517452
Note on publication
Describes the generation of a monoclonal antibody raised against ovarian tumour- associated antigens, and the subsequent study of the reactivity of the clone.
Size
319 μg Purified antibody.
Concentration
220 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 519.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 239⁰C.
![Anti-VEGF [Bevacizumab] (MABL-](/public/static/common/images/not_adv.jpg)
